We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Healthpeak Properties
DOC
$15.4B
| $1.5M | ﹤0.01% |
43,457
-2,089
| -5% | -$73.1K |
|
877
Ingredion
INGR
$6.38B
| $1.5M | ﹤0.01% |
16,112
-805
| -5% | -$67.6K |
|
878
F5
FFIV
$22.1B
| $1.5M | ﹤0.01% |
10,708
-1,481
| -12% | -$209K |
|
|
B
879
DELISTED
Barnes Group Inc.
B
| $1.49M | ﹤0.01% |
24,078
+979
| +4% | +$56.6K |
|
880
Exponent
EXPO
$2.98B
| $1.49M | ﹤0.01% |
21,588
+2,276
| +12% | +$150K |
|
|
CDK
881
DELISTED
CDK Global, Inc.
CDK
| $1.49M | ﹤0.01% |
27,264
-2,367
| -8% | -$122K |
|
|
LX
882
LexinFintech Holdings
LX
$244M
| $1.49M | ﹤0.01% |
107,209
+17,713
| +20% | +$203K |
|
883
Radian Group
RDN
$5.14B
| $1.49M | ﹤0.01% |
59,058
-29
| -0% | -$721 |
|
884
NiSource
NI
$22.4B
| $1.48M | ﹤0.01% |
53,227
-698
| -1% | -$19.1K |
|
885
Johnson Controls International
JCI
$87.5B
| $1.48M | ﹤0.01% |
36,379
-8,897
| -20% | -$375K |
|
886
VeriSign
VRSN
$25.3B
| $1.48M | ﹤0.01% |
7,671
+121
| +2% | +$22.7K |
|
887
Enphase Energy
ENPH
$4.84B
| $1.47M | ﹤0.01% |
56,330
-23,359
| -29% | -$532K |
|
888
Fox Class A
FOXA
$23.2B
| $1.47M | ﹤0.01% |
39,535
+5,847
| +17% | +$200K |
|
889
iShares US Treasury Bond ETF
GOVT
$43.6B
| $1.46M | ﹤0.01% |
56,154
+83
| +0.1% | +$2.17K |
|
|
WCN
890
Waste Connections
WCN
$42.8B
| $1.46M | ﹤0.01% |
16,025
+335
| +2% | +$30.4K |
|
|
VMW
891
DELISTED
VMware, Inc
VMW
| $1.46M | ﹤0.01% |
9,572
+451
| +5% | +$70.7K |
|
|
CSII
892
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.45M | ﹤0.01% |
29,882
+800
| +3% | +$36.4K |
|
893
TD Synnex
SNX
$19.4B
| $1.45M | ﹤0.01% |
22,504
+1,856
| +9% | +$112K |
|
894
Sun Life Financial
SLF
$45.6B
| $1.44M | ﹤0.01% |
31,692
-556
| -2% | -$25K |
|
895
Otter Tail
OTTR
$3.88B
| $1.44M | ﹤0.01% |
28,086
-6,408
| -19% | -$333K |
|
896
Avista
AVA
$3.47B
| $1.44M | ﹤0.01% |
29,861
+96
| +0.3% | +$4.57K |
|
|
GRFS
897
Grifois
GRFS
$5.16B
| $1.43M | ﹤0.01% |
61,539
-85,809
| -58% | -$1.87M |
|
898
Textron
TXT
$16.6B
| $1.43M | ﹤0.01% |
32,046
-1,742
| -5% | -$80.7K |
|
899
EXL Service
EXLS
$4.23B
| $1.43M | ﹤0.01% |
102,800
+105
| +0.1% | +$1.44K |
|
|
UCB
900
United Community Banks
UCB
$4.22B
| $1.42M | ﹤0.01% |
46,033
+595
| +1% | +$18K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.